AI Insight
MIT researchers have engineered nanoparticles capable of reprogramming immune cells directly within the body to target and destroy cancer cells and harmful immune cells. In mouse experiments, this approach successfully eliminated tumors and reversed liver damage. The technology bypasses the need for extracting, modifying, and reinfusing immune cells, as required in current cell-based immunotherapies.
Why it matters
This breakthrough could significantly reduce the complexity and cost of immune-based cancer treatments compared to existing therapies like CAR-T cell treatment, which requires extensive laboratory processing. The approach may also enable new treatment options for autoimmune diseases by targeting problematic immune cells in situ.
Understand the Science
MIT scientists have developed nanoparticles that reprogram immune cells directly inside the body to attack cancer and harmful immune cells, eliminating tumors and reversing liver damage in mouse experiments. The breakthrough could make powerful immune therapies dramatically simpler and less expensive while opening new possibilities for treating cancer and autoimmune diseases.
Source: MIT scientists turn immune cells into cancer killers inside the body